An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 1 - 14 of 14

  1. Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021–22: a descriptive epidemiological study

    • The Lancet Infectious Diseases
    • Background Shigellosis, traditionally a foodborne and waterborne infection, causes substantial morbidity globally.

      • Bacterial pathogens
      • Shigella
  2. Salmonella Typhimurium outbreak linked to chocolate

    • The Lancet Infectious Diseases
    • As of May 18, 2022, 369 cases of confirmed and probable Salmonella Typhimurium linked to chocolate products from Belgium have been reported globally. Udani Samarasekera reports. Multiple countries have been affected by an outbreak of Salmonella enterica serotype Typhimurium (hereafter S Typhimurium) linked to chocolate products produced in Belgium and distributed to at least 113 nations globally.

      • Bacterial pathogens
      • Salmonella
  3. Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis

    • The Lancet Infectious Diseases
    • Background Non-typhoidal salmonella can cause serious, life-threatening invasive infections involving the bloodstream and other normally sterile sites.

      • Bacterial pathogens
      • Salmonella
  4. Faecal microbiota transplantation: more screening for old and new pathogens

    • The Lancet Infectious Diseases
    • It has not been a good year for faecal microbiota transplantation.

      • Bacterial pathogens
  5. Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study

    • The Lancet Infectious Diseases
    • SF2a-TT15 was safe and well tolerated and induced high titres of anti-SF2a LPS IgG antibodies. These results support further evaluation of this original synthetic oligosaccharide-protein conjugate vaccine candidate for safety, immunogenicity, and protective efficacy in target populations.

      • Shigella
      • Bacterial pathogens
  6. The search for an efficacious shigella vaccine

    • The Lancet Infectious Diseases
    • Controversy surrounds the ranking by clinical importance of diarrhoeal disease pathogens.

      • Shigella
      • Bacterial pathogens
  7. Colistin resistance in China: from outer membrane to One Health

    • The Lancet Infectious Diseases
    • The use of antibiotics anywhere could select antibiotic-resistant bacteria everywhere. Reducing the use of antibiotics in farm animals is consequently fundamental to preserve the current and future benefits of antibiotics for people.

      • Bacterial pathogens
  8. Extended-spectrum β-lactamase-producing Escherichia coli

    • The Lancet Infectious Diseases
    • We read with interest the study by Michaela J Day and colleagues,1 which announced that the correlation between foodborne extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and human-derived isolates was low, and that the human-to-human, oral–faecal route contributed more to the transmission of human-derived ESBL-producing E coli than the food chain.

      • Bacterial pathogens
  9. Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial

    • The Lancet Infectious Diseases
    • The encouraging safety and immunogenicity of ETVAX and benefit of dmLT adjuvant in young children support its further assessment for protective efficacy in children in enterotoxigenic E coli-endemic areas.

      • Bacterial pathogens
  10. Vibrio vulnificus casualties during the American Civil War

    • The Lancet Infectious Diseases
    • An estimated 700 000 soldiers belonging to the Union Army and the Confederate States Army died in the 1861–65 American Civil War.1 Many camp epidemics attributed to dysentery, typhoid fever, measles, smallpox, cholera, and malaria spread quickly among the troops, affecting the Confederate Army more and surely to some extent shaping the outcome of the war.2

      • Bacterial pathogens
      • Vibrio
  11. Development of effective vaccines for enterotoxigenic Escherichia coli

    • The Lancet Infectious Diseases
    • Enterotoxigenic Escherichia coli (ETEC) is a leading cause of diarrhoea in children in low-income and middle-income countries (children's diarrhoea) and international travellers (travellers' diarrhoea).1,2 ETEC strains produce heterogeneous fimbrial or non-fimbrial adhesins (of which there are >25), which attach bacteria to host receptors for colonisation in human small intestines and deliver heat-labile and heat-stable enterotoxins to small intestine epithelia to disrupt homoeostasis and

      • Bacterial pathogens
  12. Non-typhoidal salmonella: invasive, lethal, and on the loose

    • The Lancet Infectious Diseases
    • In The Lancet Infectious Diseases, the GBD 2017 Non-Typhoidal Salmonella Invasive Disease Collaborators1 estimate the global burden of invasive non-typhoidal salmonella disease using Bayesian meta-regression tools. The results show a high but decreasing number of cases since 2005 with a continuously high case fatality rate, consistent with previous estimates.

      • Salmonella
      • Bacterial pathogens
  13. A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations

    • The Lancet Infectious Diseases
    • On June 13, 2019, the US Food and Drug Administration (FDA)1 issued a safety alert concerning the risk of serious adverse reactions due to transmission of multidrug-resistant organisms through faecal microbiota transplantations (FMTs). This alert was in response to transmission of an extended-spectrum β-lactamase-producing Escherichia coli strain from a faeces donor to two immunocompromised recipients.

      • Bacterial pathogens
  14. Infectious disease surveillance update

    • The Lancet Infectious Diseases
    • Three deaths have been reported in the biggest ever outbreak of listeriosis in Spain, which was first reported on Aug 16. As of Sept 6, 204 cases of listeria infection have been reported in Andalusia, with most cases reported in Seville (n=162). The outbreak has been linked to a pork product made by a company based in Seville. The factory has been closed and the pork products recalled from shops. Five women have also had miscarriages due to their illness.

      • Bacterial pathogens
      • Vibrio
      • Bacterial pathogens